Shanrong Biotechnology Corp
Shanrong Biotechnology Corp. does not have significant operations. Previously, it was operated as a project management and executive consulting company. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Torrance, California.
Shanrong Biotechnology Corp (SRBT) - Total Liabilities
Latest total liabilities as of June 2024: $677.83K USD
Based on the latest financial reports, Shanrong Biotechnology Corp (SRBT) has total liabilities worth $677.83K USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanrong Biotechnology Corp - Total Liabilities Trend (2008–2023)
This chart illustrates how Shanrong Biotechnology Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shanrong Biotechnology Corp Competitors by Total Liabilities
The table below lists competitors of Shanrong Biotechnology Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IVANHOE MINES-A
BE:IYAA
|
Germany | €817.88 Million |
|
HEXAGON -B- - Dusseldorf Stock Exchang
DU:HXGB
|
Germany | €6.74 Billion |
|
BlackRock Long-Term Municipal Advantage Trust
NYSE:BTA
|
USA | $83.96 Million |
Liability Composition Analysis (2008–2023)
This chart breaks down Shanrong Biotechnology Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 424.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanrong Biotechnology Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanrong Biotechnology Corp (2008–2023)
The table below shows the annual total liabilities of Shanrong Biotechnology Corp from 2008 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $662.16K | +580.67% |
| 2022-12-31 | $97.28K | +52.03% |
| 2017-12-31 | $63.99K | +757.77% |
| 2016-12-31 | $7.46K | +80.45% |
| 2015-12-31 | $4.13K | +100.00% |
| 2014-12-31 | $2.07K | -99.95% |
| 2009-12-31 | $4.17 Million | +2.82% |
| 2008-12-31 | $4.06 Million | -- |